SCHEMBL24894354

SCHEMBL24894354

COCC1CCC2(COC(C)C)CCCN12

nearest known ligand 0.33

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
KRAS P01116 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24681036 1.00 KRAS (0.33) KRAS
SCHEMBL26501987 0.91
SCHEMBL24616526 0.86 KRAS (0.35) KRAS
SCHEMBL24858463 0.86 KRAS (0.35) KRAS
SCHEMBL26734669 0.85 KRAS (0.33) KRAS
SCHEMBL26727836 0.85
SCHEMBL24680309 0.85 KRAS (0.33) KRAS
SCHEMBL26899448 0.85 KRAS (0.33) KRAS
SCHEMBL26885334 0.85
SCHEMBL24680284 0.84 KRAS (0.31) KRAS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024055112-A1 BIFUNCTIONAL COMPOUNDS AND PHARMACEUTICAL USES THEREOF Risen (Suzhou) Pharma Tech Co., Ltd. (CN) 2024-03-21 WO disclosed
WO-2023284730-A1 ALKYLIDENE DERIVATIVES AS KRAS INHIBITORS NIKANG THERAPEUTICS, INC. (US) 2023-01-19 WO disclosed